Status: Recruiting
Novel Digital Application for Patients With Acute Leukemia
This research study is evaluating to examine the efficacy of a novel a self-administered digital application (DREAMLAND) for improving patients' long-term quality of life and psychological outcomes for patients with acute myeloid leukemia undergoing intensive chemotherapy.
Participants needed: 200
Trial details
Age: 18-120Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: Nov 10, 2025Locations: 3
Eligibility criteria
Hospitalized patients (age > 18 years) with a diagnosis of AML. [+2]
Patients with a diagnosis of acute promyelocytic leukemia [+1]